These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34389694)

  • 1. Clinical Positioning of the IAP Antagonist Tolinapant (ASTX660) in Colorectal Cancer.
    Crawford N; Stott KJ; Sessler T; McCann C; McDaid W; Lees A; Latimer C; Fox JP; Munck JM; Smyth T; Shah A; Martins V; Lawler M; Dunne PD; Kerr EM; McDade SS; Coyle VM; Longley DB
    Mol Cancer Ther; 2021 Sep; 20(9):1627-1639. PubMed ID: 34389694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The non-peptidomimetic IAP antagonist ASTX660 sensitizes colorectal cancer cells for extrinsic apoptosis.
    Knoll G; Ehrenschwender M
    FEBS Open Bio; 2021 Mar; 11(3):714-723. PubMed ID: 33484626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual Antagonist of cIAP/XIAP ASTX660 Sensitizes HPV
    Xiao R; An Y; Ye W; Derakhshan A; Cheng H; Yang X; Allen C; Chen Z; Schmitt NC; Van Waes C
    Clin Cancer Res; 2019 Nov; 25(21):6463-6474. PubMed ID: 31266830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Next-generation hypomethylating agent SGI-110 primes acute myeloid leukemia cells to IAP antagonist by activating extrinsic and intrinsic apoptosis pathways.
    Dittmann J; Haydn T; Metzger P; Ward GA; Boerries M; Vogler M; Fulda S
    Cell Death Differ; 2020 Jun; 27(6):1878-1895. PubMed ID: 31831875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytoplasmic FLIP(S) and nuclear FLIP(L) mediate resistance of castrate-resistant prostate cancer to apoptosis induced by IAP antagonists.
    McCann C; Crawford N; Majkut J; Holohan C; Armstrong CWD; Maxwell PJ; Ong CW; LaBonte MJ; McDade SS; Waugh DJ; Longley DB
    Cell Death Dis; 2018 Oct; 9(11):1081. PubMed ID: 30349042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LCL161 increases paclitaxel-induced apoptosis by degrading cIAP1 and cIAP2 in NSCLC.
    Yang C; Wang H; Zhang B; Chen Y; Zhang Y; Sun X; Xiao G; Nan K; Ren H; Qin S
    J Exp Clin Cancer Res; 2016 Sep; 35(1):158. PubMed ID: 27737687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ASTX660, a Novel Non-peptidomimetic Antagonist of cIAP1/2 and XIAP, Potently Induces TNFα-Dependent Apoptosis in Cancer Cell Lines and Inhibits Tumor Growth.
    Ward GA; Lewis EJ; Ahn JS; Johnson CN; Lyons JF; Martins V; Munck JM; Rich SJ; Smyth T; Thompson NT; Williams PA; Wilsher NE; Wallis NG; Chessari G
    Mol Cancer Ther; 2018 Jul; 17(7):1381-1391. PubMed ID: 29695633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ASTX660, an antagonist of cIAP1/2 and XIAP, increases antigen processing machinery and can enhance radiation-induced immunogenic cell death in preclinical models of head and neck cancer.
    Ye W; Gunti S; Allen CT; Hong Y; Clavijo PE; Van Waes C; Schmitt NC
    Oncoimmunology; 2020; 9(1):1710398. PubMed ID: 32002309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The LEF1/CYLD axis and cIAPs regulate RIP1 deubiquitination and trigger apoptosis in selenite-treated colorectal cancer cells.
    Wu P; Shi KJ; An JJ; Ci YL; Li F; Hui KY; Yang Y; Xu CM
    Cell Death Dis; 2014 Feb; 5(2):e1085. PubMed ID: 24577083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a protein signature to enable clinical positioning of IAP inhibitors in colorectal cancer.
    McCann C; Matveeva A; McAllister K; Van Schaeybroeck S; Sessler T; Fichtner M; Carberry S; Rehm M; Prehn JHM; Longley DB
    FEBS J; 2021 Sep; 288(18):5374-5388. PubMed ID: 33660894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonism of inhibitors of apoptosis proteins reveals a novel, immune response-based therapeutic approach for T-cell lymphoma.
    Ferrari N; Ward G; Gewinner C; Davis MP; Jueliger S; Saini H; Munck J; Smyth T; Ferraldeschi R; Keer H; Lyons J; Sims MJ
    Blood Adv; 2021 Oct; 5(20):4003-4016. PubMed ID: 34474469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Andrographis overcomes 5-fluorouracil-associated chemoresistance through inhibition of DKK1 in colorectal cancer.
    Zhao Y; Wang C; Goel A
    Carcinogenesis; 2021 Jun; 42(6):814-825. PubMed ID: 33822896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel smac mimetic ASTX660 (Tolinapant) and TNF-α synergistically induce necroptosis in bladder cancer cells in vitro upon apoptosis inhibition.
    Wang L; Hu C; Zhao Y; Hu X
    Biochem Biophys Res Commun; 2022 Apr; 602():8-14. PubMed ID: 35247703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IAP antagonists sensitize murine osteosarcoma cells to killing by TNFα.
    Shekhar TM; Miles MA; Gupte A; Taylor S; Tascone B; Walkley CR; Hawkins CJ
    Oncotarget; 2016 Jun; 7(23):33866-86. PubMed ID: 27129149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GDC-0152 induces apoptosis through down-regulation of IAPs in human leukemia cells and inhibition of PI3K/Akt signaling pathway.
    Hu R; Li J; Liu Z; Miao M; Yao K
    Tumour Biol; 2015 Feb; 36(2):577-84. PubMed ID: 25273171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. USP11-dependent selective cIAP2 deubiquitylation and stabilization determine sensitivity to Smac mimetics.
    Lee EW; Seong D; Seo J; Jeong M; Lee HK; Song J
    Cell Death Differ; 2015 Sep; 22(9):1463-76. PubMed ID: 25613375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lobaplatin induces pyroptosis through regulating cIAP1/2, Ripoptosome and ROS in nasopharyngeal carcinoma.
    Chen Z; Xu G; Wu D; Wu S; Gong L; Li Z; Luo G; Hu J; Chen J; Huang X; Chen C; Jiang Z; Li X
    Biochem Pharmacol; 2020 Jul; 177():114023. PubMed ID: 32413426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WX20120108, a novel IAP antagonist, induces tumor cell autophagy via activating ROS-FOXO pathway.
    Ding R; Wang X; Chen W; Li Z; Wei AL; Wang QB; Nie AH; Wang LL
    Acta Pharmacol Sin; 2019 Nov; 40(11):1466-1479. PubMed ID: 31316176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer.
    Liu T; Zhang X; Du L; Wang Y; Liu X; Tian H; Wang L; Li P; Zhao Y; Duan W; Xie Y; Sun Z; Wang C
    Mol Cancer; 2019 Mar; 18(1):43. PubMed ID: 30890168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. H3K27 acetylation-induced lncRNA EIF3J-AS1 improved proliferation and impeded apoptosis of colorectal cancer through miR-3163/YAP1 axis.
    Liu D; Zhang H; Cong J; Cui M; Ma M; Zhang F; Sun H; Chen C
    J Cell Biochem; 2020 Feb; 121(2):1923-1933. PubMed ID: 31709617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.